奇正藏药最新筹码趋于集中

Core Viewpoint - Qizheng Tibetan Medicine has experienced a decline in the number of shareholders for the second consecutive period, indicating potential shifts in investor sentiment and market dynamics [2] Shareholder Information - As of September 20, the number of shareholders for Qizheng Tibetan Medicine was 33,802, a decrease of 2,190 from the previous period (September 10), representing a decline of 6.08% [2] - This marks the second consecutive decline in the number of shareholders [2] Stock Performance - The closing price of Qizheng Tibetan Medicine on the reporting date was 26.48 yuan, reflecting an increase of 1.57%, although the stock has cumulatively decreased by 4.68% since the concentration of shares began [2] - The stock experienced one increase and eight decreases over the specific trading days [2] Financing and Margin Data - As of September 23, the latest margin trading balance for the stock was 178 million yuan, with the financing balance also at 178 million yuan [2] - Since the concentration of shares began, the financing balance has decreased by 31.9093 million yuan, a decline of 15.23% [2] Financial Performance - In the first half of the year, Qizheng Tibetan Medicine achieved operating revenue of 1.175 billion yuan, representing a year-on-year growth of 16.36% [2] - The net profit for the same period was 358 million yuan, reflecting a year-on-year increase of 10.04% [2] - The basic earnings per share were reported at 0.6756 yuan, with a weighted average return on equity of 8.58% [2]